MCE 的所有產品僅用作科學研究或藥證申報,，我們不為任何個人用途提供產品和服務。

TM5275 sodium

CAS No. : 1103926-82-4

產品活性：TM5275 sodium is a plasminogen activator inhibitor (PAI-1) with an IC₅₀ of 6.95 μM.

研究領域：Metabolic Enzyme/Protease

作用靶點：PAI-1

In Vitro: Docking studies shows that TM5275 binds to strand 4 of the A β-sheet (s4A) position of PAI-1. TM5275 is a selective PAI-1 and (up to 100?μM) does not interfere with other serpin/serine protease systems. TM5275 at concentrations of 20 and 100 μM significantly prolongs the retention of tPA-GFP on VECs by inhibiting tPA-GFP-PAI-1 high-molecular-weight complex formation. TM5275 enhances the time-dependent accumulation of plasminogen as well as the dissolution of fibrin clots on and around the tPA-GFP-expressing cells. Cell viability at 72 h treatment is decreased with 70-100 μM TM5275 in ES-2 and JHOC-9 cells. From 48 h up to 96 h, cell growth is suppressed with 100 μM TM5275. Active PAI-1 in cell culture media is significantly decreased in cells treated with 100 μM TM5275 compared to control treatment. TM5275 is suggested to exert anti-proliferative effects in ovarian cancer with high PAI-1 expression.

In Vivo: TM5275 exhibits a favorable pharmacokinetics profile and very low toxicity to mice and rats. In rat thrombosis models. Blood clot weights are significantly lower in rats administered 10 and 50?mg/kg of TM5275 (60.9±3.0 and 56.8±2.8?mg, respectively) than in vehicle-treated rats (72.5±2.0?mg). The antithrombotic effectiveness of TM5275 (50?mg/kg) is equivalent to that of ticlopidine (500?mg/kg), a reference antithrombotic compound. Plasma concentration of TM5275 reaches 17.5±5.2?μM after a dose of 10?mg/kg. TM5275 (5?mg/kg) combined with tPA (0.3?mg/kg) significantly enhances the antithrombotic effect of tPA (0.3?mg/kg) alone and provides a benefit similar to that of a high tPA dose (3?mg/kg).

相關產品：Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Angiogenesis-Related Compound Library  |  Targeted Diversity Library  |  Coagulation and Anti-coagulation Compound Library  |  ZK824190 hydrochloride  |  Geodin  |  UKI-1  |  TM5441  |  UCD38B hydrochloride  |  UK-371804  |  AZ3976  |  Loureirin B  |  Tiplaxtinin  |  Anecortave acetate  |  ZK824859 hydrochloride  |  Toddalolactone  |  TM5007  |  CDE-096  |  28-O-β-D-Glucopyranosyl pomolic acid  |  Diaplasinin  |  Angstrom6  |  Aleplasinin  |  Upamostat

熱門產品線：重組蛋白  |  化合物庫  |  天然產物  |  熒光染料  |  PROTAC  |  同位素標記物  |  寡核苷酸  |  抗體  |  點擊化學

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫，我們致力于為*科研客戶提供前沿的高品質小分子活性化合物,；
•   50,000 多種高選擇性抑制劑,、激動劑涉及各熱門信號通路及疾病領,；
•   產品種類涵蓋各種重組蛋白,，多肽，常用試劑盒 ,，更有 PROTAC,、ADC 等特色產品，廣泛應用于新藥研發(fā),、生命科學等科研項目,；
•   提供虛擬篩選，離子通道篩選,，代謝組學分析檢測分析,，藥物篩選等專業(yè)技術服務；
•   設有專業(yè)的實驗中心和嚴格的質控,、驗證體系；
•   提供 LC/MS,、NMR,、HPLC、手性分析,、元素分析等各項質檢報告,，確保產品的高純度、高品質,；
•   產品的生物活性多經各國客戶實驗驗證,；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業(yè)團隊跟蹤最新的制藥及生命科學研究進展，為您提供*新的活性化合物,；
•   與世界各大制藥公司及著名科研機構建立了長期的合作,。